Cargando…

NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced Fatal Hepatitis Through the Upregulation of A20 Expression in Hepatocytes

Increasing evidence suggests that NODs are involved in liver diseases; however, the underlying mechanisms remain obscure. In the present study, we analyzed the effect of NOD1 agonist pretreatment on acute liver failure induced by lipopolysaccharide (LPS) in D-galactosamine (D-GalN)-sensitized mice....

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Fang, Deng, Fuxue, Xu, Pan, Li, Shiying, Wang, Xuefu, Hu, Peng, Ren, Hong, Tong, Shiwen, Yin, Wenwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969647/ https://www.ncbi.nlm.nih.gov/pubmed/33746949 http://dx.doi.org/10.3389/fimmu.2021.603192

Ejemplares similares

Short‐term fasting attenuates lipopolysaccharide/D‐galactosamine‐induced acute liver failure through Sirt1‐autophagy signaling in mice
por: Long, Boyu, et al.
Publicado: (2023)

Nature and mechanisms of hepatocyte apoptosis induced by d-galactosamine/lipopolysaccharide challenge in mice
por: WU, YI-HANG, et al.
Publicado: (2014)

Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats
por: TANAKA, MASATAKE, et al.
Publicado: (2014)

Protective Effect of Danhong Injection on Acute Hepatic Failure Induced by Lipopolysaccharide and D-Galactosamine in Mice
por: Wang, Ying, et al.
Publicado: (2014)

Lysimachiae Herba Inhibits Inflammatory Reactions and Improves Lipopolysaccharide/D-Galactosamine-Induced Hepatic Injury
por: Jeong, Yun Hee, et al.
Publicado: (2021)

Asiatic Acid Exhibits Anti-inflammatory and Antioxidant Activities against Lipopolysaccharide and d-Galactosamine-Induced Fulminant Hepatic Failure
por: Lv, Hongming, et al.
Publicado: (2017)

Protective Effect of Luteolin on D-Galactosamine (D-Gal)/Lipopolysaccharide (LPS) Induced Hepatic Injury by in Mice
por: Pu, Yiwei, et al.
Publicado: (2021)

Shikonin protects against D-Galactosamine and lipopolysaccharide-induced acute hepatic injury by inhibiting TLR4 signaling pathway
por: Lin, Meng-Xiang, et al.
Publicado: (2017)

Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
por: Perego, Jessica, et al.
Publicado: (2017)

Co-administration of lipopolysaccharide and d-galactosamine induces genotoxicity in mouse liver
por: Dong, Wenjing, et al.
Publicado: (2021)

Levosimendan Increases Survival in a D-Galactosamine and Lipopolysaccharide Rat Model
por: Sakaguchi, Tatsuma, et al.
Publicado: (2022)

Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis
por: Huang, Sha, et al.
Publicado: (2022)

The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury
por: Li, Jin, et al.
Publicado: (2017)

Protective Role of Mytilus edulis Hydrolysate in Lipopolysaccharide-Galactosamine Acute Liver Injury
por: Starikova, Eleonora, et al.
Publicado: (2021)

Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure
por: Feng, Bo, et al.
Publicado: (2013)

Crocetin protects against fulminant hepatic failure induced by lipopolysaccharide/D-galactosamine by decreasing apoptosis, inflammation and oxidative stress in a rat model
por: Gao, Ke, et al.
Publicado: (2019)

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice
Publicado: (1987)

The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice
por: Li, Jian, et al.
Publicado: (2019)

Deficiency of interleukin-19 exacerbates lipopolysaccharide/D-galactosamine-induced acute liver failure
por: FUJIMOTO, Yasuyuki, et al.
Publicado: (2020)

Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice
por: Alhareth, Dhafer Y., et al.
Publicado: (2023)

A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice
por: Feng, Bo, et al.
Publicado: (2009)

BRP, a polysaccharide fraction isolated from Boschniakia rossica, protects against galactosamine and lipopolysaccharide induced hepatic failure in mice
por: Quan, Jishu, et al.
Publicado: (2014)

The Protective Role of Pregnane X Receptor in Lipopolysaccharide/D-galactosamine-induced Acute Liver Injury
por: Wang, Kun, et al.
Publicado: (2009)

Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse
por: Zhang, Pan, et al.
Publicado: (2014)

Protective Effects of Costunolide Against D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice
por: Mao, Jingxin, et al.
Publicado: (2018)

Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A
por: Lv, Hongming, et al.
Publicado: (2019)

Protective Properties of Laggera alata Extract and its Principle Components Against d-Galactosamine-Injured Hepatocytes
por: Wu, Yi-Hang, et al.
Publicado: (2012)

Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
por: Raish, Mohammad, et al.
Publicado: (2016)

Chicoric acid ameliorate inflammation and oxidative stress in Lipopolysaccharide and d‐galactosamine induced acute liver injury
por: Li, Zheng, et al.
Publicado: (2020)

Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice
por: Wu, Yi-Long, et al.
Publicado: (2022)

Luzindole attenuates LPS/d-galactosamine-induced acute hepatitis in mice
por: Luo, Yisheng, et al.
Publicado: (2019)

Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice
por: Okumura, Akinori, et al.
Publicado: (2017)

Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway
por: Pan, Chen-wei, et al.
Publicado: (2017)

The Nod2 Agonist Muramyl Dipeptide Cooperates with the TLR4 Agonist Lipopolysaccharide to Enhance IgG2b Production in Mouse B Cells
por: Lee, Sang-Hoon, et al.
Publicado: (2019)

Insulin expressing hepatocytes not destroyed in transgenic NOD mice
por: Tabiin, Muhammad T, et al.
Publicado: (2004)

Spred2 Deficiency Exacerbates D-Galactosamine/Lipopolysaccharide -induced Acute Liver Injury in Mice via Increased Production of TNFα
por: Yang, Xu, et al.
Publicado: (2018)

Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
por: Prakash, Thazha P., et al.
Publicado: (2014)

Stattic alleviates acute hepatic damage induced by LPS/d-galactosamine in mice
por: Li, Sijia, et al.
Publicado: (2021)

Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice
por: Dong, Lin, et al.
Publicado: (2017)

Protective effect of ultrasonication-processed ginseng berry extract on the D-galactosamine/lipopolysaccharide-induced liver injury model in rats
por: Nam, Yoonjin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b1evncv4856bttv5balvrq58fg